Pharmabiz2h
Medical PG and PhD educators urge NMC to reverse discriminatory policy
Medical PG and PhD educators urge NMC to reverse discriminatory policy: Our Bureau, New Delhi Friday, April 4, 2025, 08:00 ...
Pharmabiz37m
Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D centre in Basel
Basel, Switzerland Friday, April 4, 2025, 10:00 Hrs [IST] ...
Pharmabiz2h
Need for accurate testing solutions are higher than ever as chikungunya outbreaks increase: Dr Sameer Bhati
Shardul Nautiyal, Mumbai Friday, April 4, 2025, 08:00 Hrs [IST] ...
Pharmabiz2h
Madhya Pradesh is free from counterfeit and substandard drugs: Dr. Shobhit Khoshta
Madhya Pradesh is free from counterfeit and substandard drugs: Dr. Shobhit Khoshta: Peethaambaran Kunnathoor, Chennai Friday, April 4, 2025, 08:00 Hrs [IST] Dr. Shobhit Khoshta, t ...
Pharmabiz2h
Lifesciences industry sees significant shifts with digital transformation & increased M&As: Chandra Ambadipudi
Lifesciences industry sees significant shifts with digital transformation & increased M&As: Chandra Ambadipudi: Nandita Vijayasimha, Bengaluru Friday, April 4, 2025, 08:00 Hrs [IS ...
Pharmabiz16h
BioMarin Pharma’s phase 3 PEGASUS trial evaluating Palynziq in adolescents with phenylketonuria meets primary efficacy endpoint
San Rafael, California Thursday, April 3, 2025, 18:00 Hrs [IST] ...
Pharmabiz21h
Jay Bhattacharya begins tenure as 18th director of the National Institutes of Health
Jay Bhattacharya begins tenure as 18th director of the National Institutes of Health: Bethesda, Maryland Thursday, April 3, ...
Pharmabiz17h
SEKISUI Diagnostics launches Metrix COVID/Flu Test for use at the point-of-care and home
SEKISUI Diagnostics launches Metrix COVID/Flu Test for use at the point-of-care and home: Burlington, Massachusetts Thursday, April 3, 2025, 17:00 Hrs [IST] SEKISUI Diagnostics, a ...
Pharmabiz19h
Senhwa Biosciences announces positive data from phase 1/expansion trial of Silmitasertib for basal cell carcinoma treatment
Senhwa Biosciences announces positive data from phase 1/expansion trial of Silmitasertib for basal cell carcinoma treatment: Taipei, Taiwan Thursday, April 3, 2025, 15:00 Hrs [IST ...
Pharmabiz17h
Wish medical devices also get the exemption from US reciprocal tariff, says MTaI
Wish medical devices also get the exemption from US reciprocal tariff, says MTaI: Our Bureau, New Delhi Thursday, April 3, 2025, 17:35 Hrs [IST] Expressing relief on the US Govern ...
Pharmabiz17h
India positioned to lead South Asia in AI adoption in healthcare, driving efficiency, access, and innovation: BCG report
India positioned to lead South Asia in AI adoption in healthcare, driving efficiency, access, and innovation: BCG report: Our Bureau, Bengaluru Thursday, April 3, 2025, 17:15 Hrs ...
Pharmabiz17h
Alcon introduces the first fully personalized LASIK treatment, wavelight plus, in India with CDSCO approval
Alcon introduces the first fully personalized LASIK treatment, wavelight plus, in India with CDSCO approval: Our Bureau, Bengaluru Thursday, April 3, 2025, 16:45 Hrs [IST] Alcon, ...